|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/4985 | (2006.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3419978 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17705705.6 |
| Date of filing the European patent application | 2017-02-10 | |
| (97) | Date of publication of the European application | 2019-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-15 |
| (46) | Date of publication of the claims translation | 2020-06-10 |
| (86) | Number | PCT/IB2017/050748 |
| Date | 2017-02-10 |
| (87) | Number | WO 2017/144995 |
| Date | 2017-08-31 |
| (30) | Number | Date | Country code |
| 201662299130 P | 2016-02-24 | US |
| (72) |
BROWN, Matthew Frank, US
DERMENCI, Alpay, US
FENSOME, Andrew, US
GERSTENBERGER, Brian Stephen, US
HAYWARD, Matthew Merrill, US
OWEN, Dafydd Rhys, US
WRIGHT, Stephen Wayne, US
XING, Li Huang, US
YANG, Xiaojing, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirazolo[1,5-a]pirazin-4-ilo dariniai, kaip JAK inhibitoriai |
| PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES AS JAK-INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2026-01-26 | 10 | 231.00 EUR |
| 2027-02-10 |